Document is current
Any future updates will be listed below
-
Authors
Revicki, Dennis A.
Lavoie, Sara https://orcid.org/0000-0003-4561-4746
Speck, Rebecca M.
Puelles, Jorge
Kuo, Braden
Camilleri, Michael
Almansa, Cristina
Parkman, Henry P.
-
Funding
Funding for this research was provided by:
Takeda Pharmaceuticals U.S.A.
- License Information
-
More Information
Article History
Received: 24 July 2018
Accepted: 31 October 2018
First Online: 13 December 2018
Ethics approval and consent to participate
: All methods and materials, including the study protocol, were approved by an Institutional Review Board (Chesapeake IRB, Columbia, MD 21046 [now Advarra]), reference number: Pro00022109. Written informed consent was obtained from all patients prior to initiating the interview.
: Not applicable.
: JP and CA are employees of Takeda Pharmaceuticals, the study sponsor who provided funding for this study. The study sponsor was involved in the design of the study, interpretation of the data, and preparation, review and approval of the manuscript. DAR, RMS, and SL are employed by Evidera, a company that received funding from Takeda for time spent on this research. As Evidera employees, they work with a variety of companies and organizations and are expressly prohibited from receiving any payment or honoraria directly from these organizations for services rendered. MC, HPP, and BK serve as advisors to Takeda Pharmaceuticals and conduct research supported by Takeda Pharmaceuticals. They receive no personal financial remuneration.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
